Pattern Group Stock Recovers from 52-Week Low Ahead of Key Earnings, Lock-Up Expiry
IPO Michael Okonkwo

Pattern Group Stock Recovers from 52-Week Low Ahead of Key Earnings, Lock-Up Expiry

Pattern Group shares rose 1.7% to $10.89, recovering from a 52-week low of $8.92. The stock remains 22% below its $14 IPO price as the market anticipates earnings on March 5 and a lock-up expiry on March 9.

PTRN
SanDisk Shares Rebound on CEO's Multi-Year Data Center Contract Strategy
Technology Sarah Chen

SanDisk Shares Rebound on CEO's Multi-Year Data Center Contract Strategy

SanDisk shares gained 3.5% Thursday morning as CEO David Goeckeler detailed a strategic pivot toward multi-year contracts with data center customers, helping the stock recover from a recent short-seller-driven decline.

SNDK
Resideo Shares Retreat After Sharp Rally as 2026 Outlook and Spin-Off Plan Scrutinized
Earnings James Calloway

Resideo Shares Retreat After Sharp Rally as 2026 Outlook and Spin-Off Plan Scrutinized

Resideo Technologies shares pulled back in early trading Thursday, giving back a portion of the previous session's 14% surge. The move follows the company's release of its first comprehensive 2026 financial outlook and details on its planned business separation.

REZI HON
Fermi Secures Key Texas Permit for 6-GW Project Matador
Regulation James Calloway

Fermi Secures Key Texas Permit for 6-GW Project Matador

Fermi Inc. has obtained the final air-quality permit from Texas regulators for its 6-gigawatt Project Matador, allowing major construction to proceed. The stock edged lower premarket as investors also monitor a March 6 securities lawsuit deadline and a March 30 earnings call.

FRMI SIEGY
Celldex Shares Pull Back After Barzolvolimab Enrollment Milestone
Markets Daniel Marsh

Celldex Shares Pull Back After Barzolvolimab Enrollment Milestone

Celldex Therapeutics shares retreated about 4% in premarket trading Thursday, giving back some of the prior session's 24% surge. The biotech completed patient enrollment for two key Phase 3 studies of its mast cell inhibitor barzolvolimab six months early.

CLDX
Figure Technology Shares Rally Ahead of Q4 Earnings Report
Earnings James Calloway

Figure Technology Shares Rally Ahead of Q4 Earnings Report

Figure Technology Solutions shares advanced premarket Thursday, building on Wednesday's 16.5% surge as investors await fourth-quarter earnings after the close.

FIGR
Hims & Hers Faces SEC Probe, Novo Nordisk Lawsuit as Analysts Cut Targets
Regulation James Calloway

Hims & Hers Faces SEC Probe, Novo Nordisk Lawsuit as Analysts Cut Targets

Hims & Hers Health shares held steady premarket following disclosures of an SEC probe and a patent lawsuit from Novo Nordisk. Analysts at BTIG and Citi downgraded the stock, citing regulatory risks.

HIMS NVO
TeraWulf Gains Ahead of Q4 Report, Capacity Expansion in Focus
Earnings James Calloway

TeraWulf Gains Ahead of Q4 Report, Capacity Expansion in Focus

TeraWulf Inc shares edged higher in premarket trading Thursday ahead of its fourth-quarter earnings release, following significant gains earlier in the week. Analysts anticipate $43.55 million in revenue.

WULF
HP Shares Gain Premarket Despite Memory Cost Pressures and Cautious Outlook
Earnings James Calloway

HP Shares Gain Premarket Despite Memory Cost Pressures and Cautious Outlook

HP Inc. shares edged higher in premarket trading following a quarterly earnings beat, though the company cautioned about increasing memory chip costs and U.S. trade regulations. Management maintained its full-year outlook but expects results at the lower end of its forecast range.

HPQ DELL XLK
Palantir Shares Gain Amid Insider Sales, AI Sector Scrutiny
Markets Daniel Marsh

Palantir Shares Gain Amid Insider Sales, AI Sector Scrutiny

Palantir Technologies shares advanced over 4% Wednesday, closing at $134.19, as the market parsed recent insider transactions and broader sentiment toward AI-focused software names.

PLTR NVDA CRM
Tesla Shares Dip Amid Robotaxi Permit Gap, Insider Sale Filing
Technology Sarah Chen

Tesla Shares Dip Amid Robotaxi Permit Gap, Insider Sale Filing

Tesla shares declined 2.9% to $417.40 as regulatory filings revealed no autonomous test miles in California for 2025 and a director's planned stock sale. The company also faces a hiring lawsuit and weaker European sales.

TSLA BYD NVDA NVS
Navitas Semiconductor Holds Gains After Revenue Outlook, CFO Transition
Earnings James Calloway

Navitas Semiconductor Holds Gains After Revenue Outlook, CFO Transition

Navitas Semiconductor shares stabilized in premarket trading after a sharp 20% rally, driven by an upbeat first-quarter revenue forecast and the announcement of its CFO's upcoming departure.

NVTS IFNNY WOLF ON